<DOC>
	<DOCNO>NCT02266693</DOCNO>
	<brief_summary>This 8-week , pilot randomize , control trial evaluate benefit transdiagnostic Internet-based CBT ( iCBT ) young adult MDD , SAD , PD GAD . The investigator hypothesize patient receive iCBT show significant improvement anxiety symptom function , compare wait-list group . This pilot randomize control study ass efficacy transdiagnostic iCBT 60 young adult .</brief_summary>
	<brief_title>Transdiagnostic iCBT Depression Anxiety</brief_title>
	<detailed_description>Unipolar depression anxiety disorder ( particularly social anxiety disorder [ SAD ] , generalize anxiety disorder [ GAD ] panic disorder [ PD ] ) among common form mental illness . They often chronic course , frequently associate co-morbidities , significant disability , poor quality life . Published epidemiologic study indicate condition typically emerge early adolescence adulthood , often poorly recognize , result delay several year help sought . Such delay often attribute non-recognition significance symptom , lack information access service , embarrassment fear stigma , effective early treatment reduce co-morbidities improve prognosis . Cognitive behaviour therapy ( CBT ) recognize single effective psychological intervention depression anxiety , accessibility affect therapist cost long wait time OHIP-covered service . Internet-based CBT ( iCBT ) innovative alternative high accessibility cost-efficiency group CBT , comparable efficacy . Transdiagnostic model iCBT treat depression , SAD , PD GAD within one program show efficacy preliminary trial may offer even great accessibility economy , several depress anxious population treat protocol . As non-pharmacological treatment option enhance technological advance , iCBT likely appeal tech-savvy young adult . However , evaluate specifically young adult population , thus far . This 8-week , multi-site , randomize , control trial evaluate benefit trandiagnostic iCBT 60 young adult unipolar depression and/or SAD , PD GAD . We hypothesize patient receive iCBT show significant improvement depressive anxiety symptom function , compare wait-list group .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Panic Disorder</mesh_term>
	<mesh_term>Phobic Disorders</mesh_term>
	<criteria>1 . Age range ( 1829 year ) . 2 . Primary diagnosis MDD , SAD , PD and/or GAD , per DSMIVTR . 3 . A score ≥17 first 17 item Hamilton Depression Rating Scale ( HAMD ) 55 4 . A score ≥17 Hamilton Anxiety Rating Scale ( HAMA ) 56 . 5 . Score ≥50 Leibowitiz Social Anxiety Scale ( LSAS ) ,57 ≥10 Panic Disorder Severity Scale ( PDSS ) 58 and/or ≥60 Penn State Worry Questionnaire ( PSWQ ) .59 6 . Currently unmedicated stable adequate dos medication least 4 week . 7 . Comorbidities allow document . 1 . Primary diagnosis psychotic disorder anxiety disorder ( OCD , PTSD ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>29 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Cognitive Behavioural Therapy</keyword>
	<keyword>Internet Based</keyword>
	<keyword>CBT</keyword>
	<keyword>Transdiagnostic</keyword>
	<keyword>MDD</keyword>
	<keyword>PD</keyword>
	<keyword>SAD</keyword>
	<keyword>GAD</keyword>
	<keyword>iCBT</keyword>
</DOC>